Aarti Drugs (India) Executives
| AARTIDRUGS | 458.40 2.95 0.65% |
Aarti Drugs employs about 1.1 K people. The company is managed by 9 executives with a total tenure of roughly 2483 years, averaging almost 275.0 years of service per executive, having 118.22 employees per reported executive. Discussion of Aarti Drugs' management performance can provide insight into the enterprise performance.
| Harshit Savla Insider Joint Director |
| Rushikesh Deole Insider Company Officer |
Aarti |
Aarti Drugs Management Team Effectiveness
The company has return on total asset (ROA) of 0.0617 % which means that it generated a profit of $0.0617 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1224 %, meaning that it generated $0.1224 on every $100 dollars invested by stockholders. Aarti Drugs' management efficiency ratios could be used to measure how well Aarti Drugs manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aarti Drugs' Non Currrent Assets Other are relatively stable compared to the past year. As of 11/29/2024, Intangible Assets is likely to grow to about 386.7 M, while Non Current Assets Total are likely to drop slightly above 5.7 B.Aarti Drugs Quarterly Income Before Tax |
|
Aarti Drugs Workforce Comparison
Aarti Drugs Limited is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 43,863. Aarti Drugs holds roughly 1,064 in number of employees claiming about 2.43% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. Aarti Drugs Limited Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Aarti Drugs Limited Price Series Summation is a cross summation of Aarti Drugs price series and its benchmark/peer.
Aarti Drugs Notable Stakeholders
An Aarti Drugs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aarti Drugs often face trade-offs trying to please all of them. Aarti Drugs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aarti Drugs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Harshit Savla | Joint Director | Profile | |
| Rushikesh Deole | Company Officer | Profile | |
| Prakash Patil | MD, Chairman | Profile | |
| Dhanaji Kakade | Vice Technical | Profile | |
| Vishwa Savla | Director Sciences | Profile | |
| Adhish Patil | CFO Director | Profile | |
| Rashesh Gogri | MD Director | Profile | |
| Harit Shah | WholeTime Director | Profile | |
| Uday Patil | WholeTime Director | Profile |
About Aarti Drugs Management Performance
The success or failure of an entity such as Aarti Drugs Limited often depends on how effective the management is. Aarti Drugs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aarti management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aarti management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aarti Drugs is entity of India. It is traded as Stock on NSE exchange.
Aarti Drugs Workforce Analysis
Traditionally, organizations such as Aarti Drugs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aarti Drugs within its industry.Aarti Drugs Manpower Efficiency
Return on Aarti Drugs Manpower
| Revenue Per Employee | 23.6M | |
| Revenue Per Executive | 2.8B | |
| Net Income Per Employee | 1.6M | |
| Net Income Per Executive | 190.5M | |
| Working Capital Per Employee | 4.9M | |
| Working Capital Per Executive | 583.5M |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.